| 000 | 03360nam a22003975i 4500 | ||
|---|---|---|---|
| 001 | 86626 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230207040607.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 151113s2016 ii s 000 0 eng d | ||
| 020 | _a9788132222958 | ||
| 040 | _aES-MaUEC | ||
| 050 | 4 |
_aRE351 _b2016 EB |
|
| 082 | 0 | 4 | _a617.7 |
| 245 | 0 | 0 |
_aUveitis : _bAn Update _cedited by Jyotirmay Biswas, Parthopratim Dutta Majumder |
| 250 | _a1st ed. | ||
| 260 |
_aNew Delhi _bSpringer India _c2016 |
||
| 300 |
_a1 recurso en línea (X, 180 p.) _b48 ilustraciones |
||
| 336 |
_aTexto (visual) _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 505 | 0 | _aChapter 1 Advances in ocular toxoplasmosis -- Chapter 2 Viral anterior uveitis -- Chapter 3 Behçet disease -- Chapter 4 Biologicals in uveitis -- Chapter 5 Corticosteroid in uveitis -- Chapter 6 Glaucoma in uveitis -- Chapter 7 Ocular lesions in AIDS -- Chapter 8 imaging in uveitis -- Chapter 9 Immunosuppressives inuveitis and ocular inflammation -- Chapter 10 Intraocular lymphoma -- Chapter11 Intermediate uveitis -- Chapter 12 Management of inflammatory CNV.-Chapter 13 Ocular parasitic infections -- Chapter 14 Ocular sarcoidosis -- Chapter 15 Intraocular tuberculosis -- Chapter 16 Paediatric uveitis -- Chapter 17 Serpiginous choroiditis -- Chapter 18 White dot syndromes | |
| 520 | _aThis book on recent advances in uveitis provides readers with up-to-date and clinically-relevant information on 18 topics that are indispensable for everyday practice. This book is meant for bridging the gap between recent developments and their incorporation into clinical use. Written by global experts, the topics cover advances in diagnosis and treatment of distinct clinical varieties of uveitis. Additionally, the chapter on imaging describes the various imaging modalities that aid clinching the diagnosis with greater accuracy. Role of corticosteroids, their mechanism of action and various routes of drug delivery too have been discussed in detail. Optimal use of various immunomodulators, their role, dose, mechanism of action, side effects, and monitoring during patient follow-up have been elucidated in easy-to-understand tables. There are two chapters on complications in uveitis, one on glaucoma and other on choroidal neovascularization. A chapter on pediatric uveitis highlights the challenges and provides guidance to manage this special population. | ||
| 710 | 2 |
_aSpringerLink (Online service) _0Local _9106996 |
|
| 942 |
_2lcc _cLE |
||
| 650 | 7 |
_aUveítis _xDiagnóstico _9390261 _0comprobar BNE20063004344 _2embne |
|
| 650 | 7 |
_aOftalmología _0comprobar BNE19900969318 _2embne _9139186 |
|
| 700 | 1 |
_aBiswas, Jyotirmay _eeditor literario _9100485 _0Local |
|
| 700 | 1 |
_aMajumder, Parthopratim Dutta _eeditor literario _9100486 _0Local |
|
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-81-322-2295-8 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 901 | _ai9788132222958 | ||
| 907 |
_a.b12959042 _b10-10-17 _c21-11-16 |
||
| 988 | _aSpringer_Medicine_2016 | ||
| 998 |
_am _a_alco _a_vill _b08-06-17 _cm _dz _eu _feng _gii _h0 |
||
| 945 |
_aRE351 .U94 2016 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11600512 _z06-04-17 |
||
| 999 |
_c86626 _d86626 _x1 |
||